| PDF (746kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-268292
- DOI to cite this document:
- 10.5283/epub.26829
Abstract
In a three-way cross-over study the bioavailability of cefuroxime was determined in 12 healthy volunteers after oral administration of 250 mg as cefuroxime axetil (Elobact; CAS 64544-07-6) in a plain aqueous suspension and as tablets from different batches. The tablet formulations showed nearly identical pharmacokinetic parameters and were bioequivalent. The mean maximum serum concentration was ...
Owner only: item control page